Chronic Pelvic Pain Syndrome (Non-Specific)

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for chronic pelvic pain syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational and only within a multimodal management framework.

What evidence exists?

Tier C (investigational). One small case series (n=22) describes 30 to 40 percent reduction in pelvic pain VAS and improvement in quality-of-life measures following 4 to 6 leech sessions over 8 to 12 weeks, within a multimodal management plan. There are no controlled trials. Non-specific chronic pelvic pain (no identified structural cause) affects an estimated 6 to 15 percent of reproductive-age women. Standard care is multimodal: pelvic-floor physical therapy, cognitive behavioral therapy, trigger-point management, and pharmacotherapy (gabapentinoids, tricyclics, hormonal modulation). Single-modality use of any therapy is not recommended.

Main risks

• Bleeding from bite sites for 6 to 24 hours after detachment
• Bruising and tenderness over the lower abdomen, sacrum, or inner thigh for 5 to 10 days
• Local skin infection or Aeromonas infection
• Allergic reaction to leech saliva
• Triggering of additional pelvic-floor spasm if bite is near a trigger area
• Failure to address an underlying structural pathology if workup is incomplete
• Delay of evidence-based pelvic-floor physical therapy, CBT, or pharmacotherapy
• Substitution for multimodal therapy with single-modality leech sessions

Who should not consider this

• Patients with untreated structural pathology (endometriosis, fibroids, ovarian cyst, adhesions) — workup first
• Patients with active pelvic infection (PID, abscess)
• Pregnant or lactating patients
• Patients with bleeding disorders or on anticoagulants
• Patients with severe anemia
• Patients who have not engaged with pelvic-floor physical therapy and behavioral therapy

What to ask your clinician

• Has my workup excluded structural causes (endometriosis, fibroids, adhesions, ovarian pathology)?
• Am I receiving pelvic-floor physical therapy from a certified pelvic-floor PT?
• Have I been considered for cognitive behavioral therapy and pain psychology?
• Have neuropathic agents (gabapentin, duloxetine, tricyclics) been considered?
• Where exactly will the leech be placed, and what is the multimodal integration plan?
• What is the realistic expected benefit, given evidence is one small case series?

When to seek urgent care

• Sudden severe pelvic or abdominal pain (rule out acute pathology)
• Heavy or unusual vaginal bleeding
• Fever above 38.0 C / 100.4 F, chills, or pelvic tenderness
• Signs of infection (urinary, vaginal, gastrointestinal)
• Bleeding from a bite site lasting more than 24 hours
• Spreading redness, warmth, pus, or red streaks at any bite site